Should lung cancer screening be covered for Medicare beneficiaries?
9/08/2014
Researchers for the Centers for Medicare and Medicaid Services (CMS) analyze evidence on the benefits and harms of lung cancer screening by age in a study being published in Annals of Internal...
Hourly 5-minute walks 'reverse arterial damage caused by sitting'
9/08/2014
Prolonged periods of sitting can reduce the function of arteries in the legs. A new study finds that this reduced function can be avoided by taking short walking breaks.
New blood test could offer more tailored treatment of ovarian cancer
9/08/2014
A new blood test allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment is a step closer following a new study by Manchester scientists.
New blood test could offer more tailored treatment of ovarian cancer
9/08/2014
A new blood test allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment is a step closer following a new study by Manchester scientists.
Celgene Corporation has announced that data from FIRST (MM-020/IFM 07-01) - an open-label phase III randomized study of continuous REVLIMID (lenalidomide) in combination with dexamethasone in...
A minimally invasive, high-performance intervention for staging lung cancer
9/08/2014
Endoscopic biopsy of lymph nodes between the two lungs (mediastinum) is a sensitive and accurate technique that can replace mediastinal surgery for staging lung cancer in patients with potentially...
Gene patent laws must change to protect Australian healthcare consumers
9/08/2014
The Federal Court's dismissal of an appeal against the patenting of genetic mutations associated with breast and ovarian cancer highlights why patent law in Australia needs to change, Cancer...
Lung cancer study reveals new drug combination targets
9/08/2014
A Vanderbilt lung cancer patient's exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from...
Myriad Genetics, Inc. has announced that the Myriad myRisk™ Hereditary Cancer test significantly improved the detection of cancer-causing mutations by 46 percent in patients with breast...
Researchers turn to plants to help treat hemophilia
9/08/2014
People with severe hemophilia typically receive regular injections of these proteins, called clotting factors, as a treatment for the disease.